Literature DB >> 36134822

The benefits and side effects of gadolinium-based contrast agents in multiple sclerosis patients.

Elnaz Asadollahzade1, Fereshteh Ghadiri1, Zahra Ebadi1, Abdorreza Naser Moghadasi1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2022        PMID: 36134822      PMCID: PMC9574993          DOI: 10.1590/1806-9282.20220643

Source DB:  PubMed          Journal:  Rev Assoc Med Bras (1992)        ISSN: 0104-4230            Impact factor:   1.712


× No keyword cloud information.
  19 in total

Review 1.  Safety issues related to intravenous contrast agent use in magnetic resonance imaging.

Authors:  Skorn Ponrartana; Michael M Moore; Sherwin S Chan; Teresa Victoria; Jonathan R Dillman; Govind B Chavhan
Journal:  Pediatr Radiol       Date:  2021-04-19

2.  Increased Signal Intensity in the Dentate Nucleus of Patients with Multiple Sclerosis in Comparison with Neuromyelitis Optica Spectrum Disorder after Multiple Doses of Gadolinium Contrast.

Authors:  Masami Tanaka; Kazuki Nakahara; Masako Kinoshita
Journal:  Eur Neurol       Date:  2016-04-08       Impact factor: 1.710

3.  Effects of serial macrocyclic-based contrast materials gadoterate meglumine and gadobutrol administrations on gadolinium-related dentate nuclei signal increases in unenhanced T1-weighted brain: a retrospective study in 158 multiple sclerosis (MS) patients.

Authors:  Alessandra Splendiani; Marco Perri; Claudia Marsecano; Valentina Vellucci; Giulia Michelini; Antonio Barile; Ernesto Di Cesare
Journal:  Radiol Med       Date:  2017-09-27       Impact factor: 3.469

4.  High Signal Intensity in Dentate Nucleus on Unenhanced T1-weighted MR Images: Association with Linear versus Macrocyclic Gadolinium Chelate Administration.

Authors:  Tomonori Kanda; Marie Osawa; Hiroshi Oba; Keiko Toyoda; Jun'ichi Kotoku; Takahiro Haruyama; Koji Takeshita; Shigeru Furui
Journal:  Radiology       Date:  2015-01-27       Impact factor: 11.105

5.  In vivo dentate nucleus MRI relaxometry correlates with previous administration of Gadolinium-based contrast agents.

Authors:  Enrico Tedeschi; Giuseppe Palma; Antonietta Canna; Sirio Cocozza; Carmela Russo; Pasquale Borrelli; Roberta Lanzillo; Valentina Angelini; Emanuela Postiglione; Vincenzo Brescia Morra; Marco Salvatore; Arturo Brunetti; Mario Quarantelli
Journal:  Eur Radiol       Date:  2016-02-23       Impact factor: 5.315

6.  Gadodiamide and Dentate Nucleus T1 Hyperintensity in Patients With Meningioma Evaluated by Multiple Follow-Up Contrast-Enhanced Magnetic Resonance Examinations With No Systemic Interval Therapy.

Authors:  Carlo Cosimo Quattrocchi; Carlo Augusto Mallio; Yuri Errante; Vincenzo Cirimele; Luciano Carideo; Antonella Ax; Bruno Beomonte Zobel
Journal:  Invest Radiol       Date:  2015-07       Impact factor: 6.016

7.  Increasing signal intensity within the dentate nucleus and globus pallidus on unenhanced T1W magnetic resonance images in patients with relapsing-remitting multiple sclerosis: correlation with cumulative dose of a macrocyclic gadolinium-based contrast agent, gadobutrol.

Authors:  Dragan A Stojanov; Aleksandra Aracki-Trenkic; Slobodan Vojinovic; Daniela Benedeto-Stojanov; Srdjan Ljubisavljevic
Journal:  Eur Radiol       Date:  2015-06-25       Impact factor: 5.315

8.  High signal intensity in the dentate nucleus and globus pallidus on unenhanced T1-weighted MR images: relationship with increasing cumulative dose of a gadolinium-based contrast material.

Authors:  Tomonori Kanda; Kazunari Ishii; Hiroki Kawaguchi; Kazuhiro Kitajima; Daisuke Takenaka
Journal:  Radiology       Date:  2013-12-07       Impact factor: 11.105

9.  High-Signal Intensity in the Dentate Nucleus and Globus Pallidus on Unenhanced T1-Weighted Images: Evaluation of the Macrocyclic Gadolinium-Based Contrast Agent Gadobutrol.

Authors:  Alexander Radbruch; Lukas D Weberling; Pascal J Kieslich; Johanna Hepp; Philipp Kickingereder; Wolfgang Wick; Heinz-Peter Schlemmer; Martin Bendszus
Journal:  Invest Radiol       Date:  2015-12       Impact factor: 6.016

10.  Signal Change in the Dentate Nucleus on T1-Weighted MR Images After Multiple Administrations of Gadopentetate Dimeglumine Versus Gadobutrol.

Authors:  Yan Cao; Daisy Q Huang; George Shih; Martin R Prince
Journal:  AJR Am J Roentgenol       Date:  2015-12-23       Impact factor: 3.959

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.